These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 25051198

  • 1. Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2.
    Wang Z, Wang J, Li X, Xing L, Ding Y, Shi P, Zhang Y, Guo S, Shu X, Shan B.
    Int J Oncol; 2014 Oct; 45(4):1469-78. PubMed ID: 25051198
    [Abstract] [Full Text] [Related]

  • 2. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
    Fukunaga E, Inoue Y, Komiya S, Horiguchi K, Goto K, Saitoh M, Miyazawa K, Koinuma D, Hanyu A, Imamura T.
    J Biol Chem; 2008 Dec 19; 283(51):35660-7. PubMed ID: 18927080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
    Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, Zhou Z, Petros J, Frierson HF, Vessella RL, Atfi A, Dong JT.
    Oncogene; 2007 Apr 05; 26(16):2386-94. PubMed ID: 17016436
    [Abstract] [Full Text] [Related]

  • 5. Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.
    Gang X, Wang G, Huang H.
    Prostate; 2015 May 05; 75(6):561-72. PubMed ID: 25631036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y, Zhou Z, Chen C.
    Cell Death Differ; 2008 Dec 05; 15(12):1941-51. PubMed ID: 18806757
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
    Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold RJ.
    Cancer Chemother Pharmacol; 2005 Jul 05; 56(1):46-54. PubMed ID: 15791457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.
    Manna S, Singha B, Phyo SA, Gatla HR, Chang TP, Sanacora S, Ramaswami S, Vancurova I.
    J Immunol; 2013 Sep 01; 191(5):2837-46. PubMed ID: 23894194
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.
    Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, Boyce BF, Xing L.
    J Biol Chem; 2006 Feb 17; 281(7):4326-33. PubMed ID: 16373342
    [Abstract] [Full Text] [Related]

  • 13. The Nedd4-like family of E3 ubiquitin ligases and cancer.
    Chen C, Matesic LE.
    Cancer Metastasis Rev; 2007 Dec 17; 26(3-4):587-604. PubMed ID: 17726579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
    Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ.
    J Clin Oncol; 2004 Jun 01; 22(11):2108-21. PubMed ID: 15169797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.
    Williams SA, McConkey DJ.
    Cancer Res; 2003 Nov 01; 63(21):7338-44. PubMed ID: 14612532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.